ZOE.DE Zoetis Inc. R
Healthcare · Drug Manufacturers - Specialty & Generic
61.86
-0.74%
About the company
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
52-week range
Dividend deep dive
Zoetis Inc., a Drug Manufacturer in the Healthcare sector, offers a current dividend yield of 2.94% (EUR). Based on dividend yield theory, the stock currently appears undervalued, with its current yield well above its 5-year high of 1.36% and its 5-year average of 0.87%. The momentum score, value score, and overall rating score are not provided in the data.
Dividend history
Zoetis Inc. has a dividend increase streak of 5 years, classifying it as a "Challenger" in the CCC framework. The company's dividend has grown with a 3-year compound annual growth rate (CAGR) of 15.44% and a 5-year CAGR of 20.11%. The annual dividends per share in EUR have been: 0.705 in 2020, 0.8812 in 2021, 1.1456 in 2022, 1.3218 in 2023, 1.5227 in 2024, and 1.7624 in 2025. The Chowder Number for the company is 23.1, which passes the threshold of 12.0.
Dividend safety
The dividend payout ratio for Zoetis Inc. is 33.77% of earnings. The company's leverage is reflected in a debt-to-equity ratio of 293.996%. Liquidity is supported by a current ratio of 3.084 and a quick ratio of 1.575.
Quantic · Free
Read the rest of the safety verdict
Plus the key risks and what to watch next — free, no card.
AI-generated from Quantic's dividend data · Updated 30 Sep 2026 · Information, not financial advice.
Price history
Dividend profile
Yield band A stock's current dividend yield shown against its own range over the past five years — the low, average and high. Near the high end the shares look relatively cheap for the income they pay; near the low end, relatively expensive. It's the picture behind Dividend Yield Theory. Learn more → (5-year)
Payment calendar
Dividend history
Per-share dividend by year
Debt & leverage
Latest reported balance-sheet figures.
Held by 1 investor · watched by 1
Appears in these lists
ZOE.DE qualifies for these curated dividend rankings.
New to dividend investing?
Information, not financial advice.
Quantic · Free
Track ZOE.DE and your whole portfolio
Real yield, dividend safety, net-of-tax income and your path to freedom — free, no broker connection.
Need more? Pro adds portfolios, options income tracking & more AI. See Pro →